ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.
about
The diversification of the LIM superclass at the base of the metazoa increased subcellular complexity and promoted multicellular specializationGRB2 couples RhoU to epidermal growth factor receptor signaling and cell migration.Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence.The unique localization of ZFP185 at uropod of mouse T lymphocytes.Zinc finger protein 185 is a liver metastasis-associated factor in colon cancer patients.The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines.In silico functional profiling of individual prostate cancer tumors: many genes, few functions.Hepatitis B virus X protein influences enrichment profiles of H3K9me3 on promoter regions in human hepatoma cell linesBAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinomaThe global transcriptional response of isolated human islets of langerhans to glucagon-like Peptide-1 receptor agonist liraglutide.Zinc-finger proteins in health and disease.Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.Arctigenin inhibits prostate tumor cell growth in vitro and in vivo.A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma
P2860
Q21560967-B840B475-4EE6-4E0B-A001-2743D4769B20Q30155572-B27384BF-2216-4E2D-ADD4-D91A12D1839EQ30361210-C530840E-6693-4DF4-9F4F-4DF704B23C03Q33324542-8A92F457-987B-475F-9666-059657A4B2A8Q33932721-56ED4147-D40B-421E-943C-3A38A365F14EQ34662765-054A0346-0677-4455-94B7-26DA23298750Q34914039-581CE45B-F3B3-4884-8090-6AA78B6213C6Q36265498-51C9F774-5C83-4892-AD13-BC77AA895AE9Q37580644-A4C2B53A-6936-4BA1-80B0-B2F262D25AA0Q37709037-AB77072A-4A84-4071-B668-DE6BD9C5D28DQ38931043-520E0F5A-56FC-46D3-836F-CF71F5AACC2AQ41620442-3D38EF46-9AB3-4D81-B31F-C0B339A26ADAQ42469426-2EEC2D70-A5EA-448B-ABF6-AD580B77F902Q47141284-4E3EF82C-0C88-402A-A5E9-8166297AF848Q48322745-322FA121-30C1-4F32-8954-E08CB298973AQ52748426-2379ED17-7370-46B8-B935-B409DEA1FACFQ57462035-3A5006E3-5CF7-4BAE-8485-3F3519BD5681
P2860
ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
ZNF185, an actin-cytoskeleton- ...... IM protein in prostate cancer.
@en
type
label
ZNF185, an actin-cytoskeleton- ...... IM protein in prostate cancer.
@en
prefLabel
ZNF185, an actin-cytoskeleton- ...... IM protein in prostate cancer.
@en
P2093
P356
P1433
P1476
ZNF185, an actin-cytoskeleton- ...... IM protein in prostate cancer.
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1209769
P407
P577
2006-06-26T00:00:00Z
P5875
P6179
1052227916